Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | DRD2 | P14416 | 2/20 | 0.45 |
| ▸ | DRD3 | P35462 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | HTR7 | P34969 | 1/20 | 0.43 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.41 |
| ▸ | CYP21A2 | P08686 | 1/20 | 0.41 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12082219 | 0.94 | MAPT (0.51) | MAPTNPSR1DRD2DRD3MEN1 | |
| SCHEMBL15499061 | 0.91 | MAPT (0.44) | MAPTNPSR1DRD2DRD3MEN1 | |
| SCHEMBL22542091 | 0.87 | MAPT (0.51) | MAPTNPSR1DRD2DRD3MEN1 | |
| SCHEMBL18872636 | 0.86 | MAPT (0.46) | MAPTNPSR1DRD2DRD3HTR7 | |
| SCHEMBL24803641 | 0.84 | MAPT (0.43) | MAPTNPSR1DRD2DRD3HTR7 | |
| SCHEMBL24834707 | 0.81 | MAPT (0.47) | MAPTNPSR1DRD2DRD3KMT2A | |
| SCHEMBL12073571 | 0.79 | CHRM5 (0.48) | MAPTMEN1KMT2AADRB1 | |
| SCHEMBL20372819 | 0.79 | MAPT (0.51) | MAPTNPSR1HTR7ADRB1 | |
| SCHEMBL17665100 | 0.79 | MAPT (0.48) | MAPTNPSR1DRD2DRD3MEN1 | |
| SCHEMBL17432874 | 0.78 | CCR2 (0.47) | DRD2DRD3ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160366909-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF | MIDORI USA, INC. (US) | 2016-12-22 | — | — | US | disclosed |
| US-20160032038-A1 | POLYMERIC IONIC SALT CATALYSTS AND METHODS OF PRODUCING THEREOF | MIDORI USA, INC. (US) | 2016-02-04 | — | — | US | disclosed |
| US-9238845-B2 | Methods of producing sugars from biomass feedstocks | MIDORI USA, INC. (US) | 2016-01-19 | — | — | US | disclosed |
| US-20150202607-A1 | POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING CELLULOSIC MATERIALS USING SUCH CATALYSTS | Midori Renewables, Inc. (US) | 2015-07-23 | — | — | US | disclosed |
| US-20140060522-A1 | METHODS OF PRODUCING SUGARS FROM BIOMASS FEEDSTOCKS | HERCULES CAPITAL, INC. | 2014-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160366909-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF | FUT5, FUT6, OSTC | MAPT 3577/4885NPSR1 3212/4885DRD2 4449/4885 |
| US-20150202607-A1 | POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING CELLULOSIC MATERIALS USING SUCH CATALYSTS | MGAM, CEL, SI | MAPT 4450/4885NPSR1 3574/4885DRD2 4537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.